Reduced PRDX2 expression in human melanoma cells is associated with increased proliferation and migration via PRDX2 suppression of Src/ERK signaling, which also increased E-cadherin and retention of β-catenin at the adherens junction [113]. The gene discussed is SRC; the disease is melanoma.